Skip to main content
Premium Trial:

Request an Annual Quote

Sangamo, Icagen Pen Protein-Transcription Collaboration

NEW YORK, July 17 - Sangamo Biosciences said today it will develop certain cell lines for high-throughput small-molecule screening for drug developer Icagen.


Under the deal, Sangamo will use its zinc finger DNA-binding protein-transcription factor technology to build cell lines that overexpress certain proteins.


Click here for more information.

The Scan

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.

Acne-Linked Loci Found Through GWAS Meta-Analysis

Researchers in the European Journal of Human Genetics find new and known acne vulgaris risk loci with a genome-wide association study and meta-analysis, highlighting hair follicle- and metabolic disease-related genes.

Retina Cell Loss Reversed by Prime Editing in Mouse Model of Retinitis Pigmentosa

A team from China turns to prime editing to correct a retinitis pigmentosa-causing mutation in the PDE6b gene in a mouse model of the progressive photoreceptor loss condition in the Journal of Experimental Medicine.

CRISPR Screens Reveal Heart Attack-Linked Gene

Researchers in PLOS Genetics have used CRISPR screens to home in on variants associated with coronary artery disease that affect vascular endothelial function.